切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 doi: 10.3877/cma.j.issn.2096-1537.2024.07.29-0003

所属专题: 有“依”可靠-全国MDR诊疗实践项目——优秀病例展示

依拉环素治疗多重耐药鲍曼不动杆菌重症肺炎一例
张群1, 王明月1, 何梦钰1, 戴山林1, 孙文逵1,()   
  1. 1. 210029 南京,南京医科大学第一附属医院呼吸与危重症医学科
  • 收稿日期:2023-12-06
  • 通信作者: 孙文逵
  • 基金资助:
    中国博士后面上项目(2020M671396); 江苏省博士后面上项目(2020Z239)

Treatment of severe pneumonia caused by multidrug-resistant Acinetobacter baumannii with Eravacycline: a case report

Qun Zhang1, Mingyue Wang1, Mengyu He1, Shanshan Dai1, Wenkui Sun1,()   

  1. 1. Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2023-12-06
  • Corresponding author: Wenkui Sun
引用本文:

张群, 王明月, 何梦钰, 戴山林, 孙文逵. 依拉环素治疗多重耐药鲍曼不动杆菌重症肺炎一例[J/OL]. 中华重症医学电子杂志, doi: 10.3877/cma.j.issn.2096-1537.2024.07.29-0003.

Qun Zhang, Mingyue Wang, Mengyu He, Shanshan Dai, Wenkui Sun. Treatment of severe pneumonia caused by multidrug-resistant Acinetobacter baumannii with Eravacycline: a case report[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), doi: 10.3877/cma.j.issn.2096-1537.2024.07.29-0003.

本例为多重耐药鲍曼不动杆菌引起肺部感染的患者,当地医院予比阿培南联合莫西沙星抗感染,病情未见明显好转,持续出现发热症状。转入我科后予头孢哌酮舒巴坦联合替加环素治疗,患者体温恢复正常,但出现了替加环素相关的严重不良反应,包括血小板(Plt)减少、凝血功能异常和出血症状。停用替加环素后改用依拉环素抗感染,Plt逐渐恢复,凝血功能也逐渐改善,最终患者好转出院。

This case report describes a patient with pulmonary infection caused by multidrug-resistant Acinetobacter baumannii. The patient was initially treated with a combination of Biapenem and Moxifloxacin at a local hospital, but there was no significant improvement in their condition, and they continued to experience fever symptoms. After transfer to our department, the patient was treated with Cefoperazone-Sulbactam in combination with Tigecycline. The patient's body temperature returned to normal, but they developed severe adverse reactions attributed to Tigecycline, including thrombocytopenia, coagulation abnormalities, and bleeding symptoms. Tigecycline was discontinued, and the patient was switched to treatment with Eravacycline, which resulted in a gradual recovery of platelet count and improvement in coagulation function. Eventually, the patient recovered and was discharged.

图1 2023年7月20日患者胸部CT肺窗影像。图a为主动脉弓层面肺窗;图b为主肺动脉窗层面;图c为气管分叉层面;图d为右肺动脉层面
图2 患者入院后体温、Plt、Hb、Fib、APTT/PT的动态变化。图a为体温;图b为Plt/Hb;图c为Fib;图d为APTT/PT 注:Plt为血小板;Hb血红蛋白;Fib纤维蛋白原;APTT为活化部分凝血酶原时间;PT为凝血酶原时间
图3 2023年8月4日患者胸部CT肺窗影像。图a为主动脉弓层面肺窗;图b为主肺动脉窗层面;图c为气管分叉层面;图d为右肺动脉层面
1
Aydemir H, Tuz HI, Piskin N, et al. Risk factors and clinical responses of pneumonia patients with colistin-resistant Acinetobacter baumannii-calcoaceticus [J]. World J Clin Cases, 2019, 7(10): 1111-1121.
2
Gao L, Lyu Y, Li Y. Trends in drug resistance of Acinetobacter baumannii over a 10-year period: nationwide data from the China surveillance of antimicrobial resistance program [J]. Chin Med J, 2017, 130(6): 659-664.
3
梁小英,农波.多重耐药鲍曼不动杆菌的耐药机制研究[J] 检验医学与临床, 2022, 19(11): 1566-1569.
4
Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-treat resistance in Gram-negative Bacteremia at 173 US Hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents [J]. Clin Infect Dis, 2018, 67(12): 1803-1814.
5
Visalli MA, Murphy E, Projan SJ, et al. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis [J]. Antimicrob Agents Chemother (Bethesda), 2003, 47(2): 665-669.
6
宋淑萍,苏伟,郭丰,等.替加环素相关不良反应分析[J].中国继续医学教育, 2019, 11(26): 131-133.
7
陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J]中国医药科学, 2012, 2(8): 3-8.
8
Kaewpoowat Q, Ostrosky-Zeichner L. Tigecycline: a critical safety review [J]. Expert Opin Drug Saf, 2015, 14(2): 335-342.
9
Tasina E, Haidich AB, Kokkali S, et al. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis [J]. Lancet Infect Dis, 2011, 11(11): 834-844.
10
Lebowitz D, Müller CA, Balagué N, et al. Staphylococcus aureus versus Streptococcus pyogenes in hand infection [J]. Infect Dis (Lond), 2015, 47(10): 747-748.
11
Cui N, Cai H, Li Z, et al. Tigecycline-induced coagulopathy: a literature review[J]. Int J Clin Pharm, 2019, 41(6): 1408-1413.
12
Scott LJ. Eravacycline: a review in complicated intra-abdominal infections [J]. Drugs, 2019, 79(3): 315-324.
13
Zhanel GG, Baxter MR, Adam HJ, et al. In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015 [J]. Diagn Microbiol Infect Dis, 2018, 91(1): 55-62.
14
Alosaimy S, Abdul-Mutakabbir JC, Kebriaei R, et al. Evaluation of Eravacycline: a novel fluorocycline [J]. Pharmacotherapy, 2020, 40(3): 221-238.
15
Lee YR, Burton CE. Eravacycline, a newly approved fluorocycline [J]. Eur J Clin Microbiol Infect Dis, 2019, 38(10): 1787-1794.
16
Thakare R, Dasgupta A, Chopra S. Eravacycline for the treatment of patients with bacterial infections [J]. Drugs Today (Barc), 2018, 54(4): 245-254.
17
中华医学会外科学分会,中国研究型医院学会感染性疾病循证与转化专业委员会,中华外科杂志编辑部.外科常见腹腔感染多学科诊治专家共识[J].中华外科杂志, 2021, 59(3): 161-178.
18
Sy CL, Chen PY, Cheng CW, et al. Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms [J]. J Microbiol Immunol Infect, 2022, 55(3): 359-386.
19
Zeng M, Xia J, Zong Z, et al. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli [J]. J Microbiol Immunol Infect, 2023, 56(4): 653-671.
20
Kong W, Deng T, Li S, et al. Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis [J]. BMC infectious diseases, 2023, 23(1): 256.
21
Solomkin J, Evans D, Slepavicius A, et al. Assessing the efficacy and safety of Eravacycline vs Ertapenem in complicated intra-abdominal infections in the investigating Gram-negative infections treated with Eravacycline (IGNITE 1) trial: a randomized clinical trial [J]. JAMA Surg, 2017, 152(3): 224-232.
22
Solomkin JS, Gardovskis J, Lawrence K, et al. IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of Eravacycline vs Meropenem in the treatment of complicated intraabdominal infections[J]. Clin Infect Dis, 2019, 69(6): 921-929.
23
Alosaimy S, Morrisette T, Lagnf AM, et al. Clinical outcomes of Eravacycline in patients treated predominately for Carbapenem-resistant Acinetobacter baumannii [J]. Microbiol Spectr, 2022, 10(5): e0047922.
24
Hobbs ALV, Gelfand MS, Cleveland KO, et al. A retrospective, multicentre evaluation of Eravacycline utilisation in community and academic hospitals [J]. J Glob Antimicrob Resist, 2022, 29: 430-433.
[1] 宋勇, 李东炫, 王翔, 李锐. 基于数据挖掘法分析3 种超声造影剂不良反应信号[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 890-898.
[2] 季思涵, 唐新宇, 王邦杰, 狄汶洋, 王佳鸣, 查小明, 谢晖, 周文斌, 潘红, 王水. 阿贝西利在激素受体阳性、HER-2 阴性乳腺癌患者中的安全性研究[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 281-286.
[3] 张烈, 严一核, 杜洁瑜. 分泌型白细胞蛋白酶抑制因子对无创呼吸机治疗重症肺炎患者的预测效能[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 301-306.
[4] 陈桂华, 钟小玲, 谢雨, 王慧, 谢江, 杨涛毅. 合并肝脏疾病特殊健康状态儿童疫苗预防接种及时性临床分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 431-439.
[5] 李倩, 刘倩, 朱海玲, 倪娟, 任宝芹, 刘长云. 重组人生长激素治疗特发性矮小症患儿的疗效[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 346-352.
[6] 徐保平, 彭怀文, 喻怀斌, 王晓涛. 新型冠状病毒肺炎继发糖尿病酮症酸中毒合并肝门静脉积气一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 250-255.
[7] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[8] 何岩, 向文采. 七氟醚与异丙酚联合氯胺酮麻醉在疝修补术中的镇静镇痛效果及安全性[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 566-569.
[9] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[10] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[11] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[12] 吴洁柔, 王琴, 张静, 周耿标, 赖芳, 韩云. 体质量指数、血清白蛋白联合mNUTRIC评分对重症肺炎预后的意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 392-396.
[13] 袁广琴, 朱珠, 林云霞. 胸腺肽联合无创正压通气救治AECOPD并发Ⅱ型呼吸衰竭患者的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 438-441.
[14] 李芝朋, 周明虎, 董大红, 许正峰. 早期血小板动态分析对重症肺炎预后的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 475-477.
[15] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?